nabu.science
MethodologyAboutContact

 

  • Snapshot
  • Key Claims
  • Strengths & Limitations
  • Commentary
  • From the Authors
  • Author Note / Field Feedback
  • Dimension breakdown
  • Impact Profile
Free · About 5 minutes
Report #NBU-127F2179·Framework v5.5·Pipeline v0.4·Evaluated 23 Jul 2026·OECD: 3.2 Oncology·Subfield: Molecular Biology·Basis: Full text·Type: Computational simulation

Identifying and Validating Networks of Oncology Biomarkers Mined From the Scientific Literature

Kim Wager et al.Kim Wager, Dheepa Chari, Steffan N. Ho et al.·2022·10.1177/11769351221086441 ↗

Primary claim

identified biomarker relationships not known to existing interaction networks

Supported · 48/104 selected pairs were absent from named databases, but absence from databases is not full novelty proof
In brief

A practical oncology text-mining workflow surfaces plausible biomarker relationships, but its validation remains selected and unbenchmarked.

ReliabilityCaveats4 of 4 checks completeRead the entry ↓
Abstract

Biomarkers, as measurements of defined biological characteristics, can play a pivotal role in estimations of disease risk, early detection, differential diagnosis, assessment of disease progression and outcomes prediction. Studies of cancer biomarkers are published daily; some are well characterized, while others are of growing interest. Managing this flow of information is challenging for scientists and clinicians. We sought to develop a novel text-mining method employing biomarker co-occurrence processing applied to a deeply indexed full-text database to generate time-interval-delimited biomarker co-occurrence networks. Biomarkers across 6 cancer sites and a cancer-agnostic network were successfully characterized in terms of their emergence in the published literature and the context in which they are described. Our approach, which enables us to find publications based on biomarker relationships, identified biomarker relationships not known to existing interaction networks. This search method finds relevant literature that could be missed with keyword searches, even if full text is available. It enables users to extract relevant biological information and may provide new biological insights that could not be achieved by individual review of papers.

Key Claims

Primary finding · Supported

identified biomarker relationships not known to existing interaction networks

48/104 selected pairs were absent from named databases, but absence from databases is not full novelty proof

Abstract; Discussion, p. 14
Secondary · Supported

develop a novel text-mining method employing biomarker co-occurrence processing applied to a deeply indexed full-text database

workflow is implemented with specified corpus, thresholds, networks, clustering, and validation examples

Abstract; Methods, p. 2–4
Secondary · Supported

Biomarkers across 6 cancer sites and a cancer-agnostic network were successfully characterized

networks and selected biological contexts are reported across sites, though detailed validation covers selected clusters

Abstract; Results, p. 3–14
Secondary · Tentative

This search method finds relevant literature that could be missed with keyword searches

claim is plausible from relationship search design but lacks direct keyword-search comparator testing

Abstract; Conclusion, p. 14–15
Exploratory · Tentative

this approach is not limited to oncology

generalizable in principle, but only oncology seed lists and cancer networks are evaluated

Discussion, p. 8

Derived from the full evaluation — not a separate score.

Strengths · Limitations

Strengths

#methodological rigour

Clear operational text-mining workflow

The article specifies the EDRN biomarker seed set, Dimensions full-text corpus, date range, proximity rules, co-occurrence thresholds, edge weighting, clustering method, and enrichment analysis. This makes the workflow assessable even though full reproducibility is limited by missing code and proprietary corpus access.

↳ Methods, p. 2–4

#contribution

Multiple oncology network applications

The method is applied to six cancer-site networks and a cancer-agnostic network, rather than a single illustrative example. The results then examine renal, colorectal, and cancer-agnostic clusters with different contextual-validation approaches.

↳ Abstract; Results, p. 3–8; Figures 2–9

#positioning

Substantive limitation discussion

The Discussion identifies the difficulty of optimizing co-occurrence parameters and acknowledges that the method does not identify relation type, molecular nature, or negation. These limitations are concrete and tied to plausible future improvements such as sentence-level processing and context-aware models.

↳ Discussion, p. 14–15

Limitations

#contribution

No direct keyword-search benchmark

The Abstract and Conclusion state that the method finds relevant literature missed by keyword searches, but the paper does not report a head-to-head comparison against keyword-search recall or precision. This limits the strength of the claimed retrieval advantage.

↳ Abstract; Conclusion, p. 14–15

#methodological rigour

Selected validation limits performance inference

Manual validation focuses on three selected example analyses, including fastest-growing clusters and top-Mendeley publications. These examples support plausibility but do not establish systematic performance across the full 31,550-pair co-occurrence network.

↳ Methods, Contextual analysis, p. 3; Results, p. 4–14

#methodological rigour

Reproducibility constrained by unavailable code

The paper names packages and states that networks are published on NDEx, but it does not provide executable analysis code or full access to the underlying Dimensions corpus. This matters for a methods paper whose results depend on preprocessing, thresholding, and proprietary full-text indexing.

↳ Methods, p. 2–3

Does this match your read? Add your assessment ↓

Nabu Commentary

The article’s strongest scores come from a clear, assessable workflow and a coherent presentation of how full-text co-occurrence networks can surface biologically plausible biomarker relationships. The main methodological constraint is validation scope: the paper manually reviews selected high-growth clusters and Mendeley-ranked papers, but does not evaluate performance across the full network or against keyword-search baselines. The contribution is therefore best read as a useful proof-of-concept literature-mining tool rather than a validated retrieval system. Impact potential is moderate because the open-access tool and NDEx-hosted networks create a plausible route to use, while operational uptake and decision impact remain untested.

Evaluate another paper

Free · About 5 minutes · Research preview

Author Note / Field Feedback

Nabu’s assessment, alongside the field’s view.

Are you an author of this paper?

Dimension breakdown

Evidence Score

Out of 5
012345
3.4±0.2

Contribution
3.4

The paper contributes a practical full-text co-occurrence and network-analysis workflow for oncology biomarkers, applied across six cancer sites and a cancer-agnostic network. Its contribution is meaningful but incremental because co-occurrence text mining is established and the comparative advantage over keyword search is not directly tested.

Abstract; Introduction; Methods, p. 2–3; Discussion, p. 14

identified biomarker relationships not known to existing interaction networks

Methodological Rigour
3.2

The methods report the corpus, seed list, proximity window, co-occurrence thresholds, network construction, Leiden clustering, publication-growth metric, and enrichment testing. Methodological Rigour is limited by ad hoc parameter choice, selected-cluster manual validation, proprietary Dimensions dependence, and no public analysis code.

Methods, p. 2–4; Contextual analysis, p. 3; Discussion, p. 14

ad hoc analysis indicated that a 10-word window is slightly too short

Reporting
3.8

The article follows a coherent sequence from motivation to search strategy, network generation, selected validation examples, enrichment analysis, and limitations. Figures and tables support comprehension, although some abstract and conclusion language states the retrieval advantage more strongly than the reported benchmark evidence allows.

Abstract; Figure 1; Methods, p. 2–4; Conclusion, p. 14–15

The results of our searches and network analysis are summarized

Positioning
3.5

The paper positions itself against prior abstract-only, mutation-focused, and open-access-limited text-mining approaches, and it contextualizes selected biomarker clusters with cancer-biology literature and pathway databases. Contextual depth is moderated by limited engagement with formal information-retrieval benchmarking and relation-extraction alternatives.

Introduction, p. 1–2; Discussion, p. 8–14; References 4–19

these approaches, which are limited in scope

Reliability

Caveats4 of 4 checks


Internal CoherenceNoted

The paper’s methods-to-results chain is broadly coherent, with consistent reported counts and a clear mapping from network construction to validation examples. Some headline claims extend beyond the evaluation design, especially claims about keyword-search superiority and minimal noise from selected validation subsets.

Research ConductClean

The study uses published literature and does not raise an apparent ethics-review requirement. Funding, sponsorship, employee affiliations, and consulting relationships are disclosed, with no visible conduct-integrity concern in the supplied text.

Flags: 2 declared / 5 total

Reference IntegrityClean

39 references verified via PubMed, Crossref, or OpenAlex.

References not verified automatically are resolved manually within 24 hours.

Post-Publication RecordClean

No retraction or expression of concern found in Crossref (includes Retraction Watch).

Last checked: 17 Oct 2026

Sources: Crossref (incl. Retraction Watch) ✓

Impact Profile

Impact areaHealth · Generic health relevance
Type of advanceMethodological
Route to useSuggested
AdvanceExtends
CitationsFWCI 0.3
Policy · patentNot yet traced
ReachedNot reachedNot assessable or unverified
ReadinessPiloted
Foundational
Controlled
Piloted
Validated
Implementable
FoundationalImplementable

The method was demonstrated once on a large real literature corpus with manual validation of three example clusters, but has no independent confirmation or routine operational use by others.

From the paper
“It enables users to extract relevant biological information and may provide new biological insights that could not be achieved by individual review of papers.”

The paper presents its freely accessible tool as a real-world product for finding biomarker relationships and literature, but does not name a specific profession, organisation or setting that would act on the findings.

Pathway

Cancer researchers and pharmaceutical biomarker teams would use the open-access tool to surface emerging biomarker pairs and generate hypotheses for laboratory and clinical validation.

Barrier

The co-occurrence-derived relationships lack experimental confirmation and the method cannot distinguish association types, so identified pairs require wet-lab validation before therapeutic or diagnostic use.

Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3

Report an issue →

AI-generated, human-governed. Something look off? Contact us to request a review.

Keep reading

Related evaluations

Other papers Nabu has evaluated blind, starting with the same field.

  1. Platelet-derived factors dysregulate placental sphingosine-1-phosphate receptor 2 in human trophoblasts

    Freya Lyssy, Jacqueline Guettler, Beatrice A Brugger, et al. · 2023 · Basic medicine

    Primary claim

    S1PR2 was found to be significantly down-regulated in BeWo cells when co-incubated with platelet-derived factors (P = 0.0055).

    Tentative
    Evidence Score
    3.1±0.2
    Reliability
    Caveats
  2. The endogenous exposome of the pregnant mother: Placental extracellular vesicles and their effect on the maternal system

    Nadja Kupper, Berthold Huppertz · 2021 · Basic medicine

    Primary claim

    in pregnancy pathologies such as preeclampsia, quantity and quality of the placenta-derived vesicles are altered leading to a deleterious effect on the maternal vascular system.

    Tentative
    Evidence Score
    3.2±0.1
    Reliability
    Caveats
  3. Distinct maternal metabolites are associated with obesity and glucose-insulin axis in the first trimester of pregnancy

    Bandres-Meriz, Kunz, Havelund, et al. · 2023 · Clinical medicine

    Primary claim

    palmitoleoyl ethanolamine (POEA), an endocannabinoid-like lipid endogenously synthesized from palmitoleic acid, and N-acetyl-L-alanine were consistently associated with C-peptide in all the analyses

    Supported
    Evidence Score
    2.6±0.2
    Reliability
    Concerns

How the rubric works →